Michel
Prazeres Accepts Sanction for Second Violation of UFC
Anti-Doping Policy https://t.co/gWqyGG6EtI— USADA (@usantidoping)
December 23, 2021
Ultimate Fighting Championship welterweight Michel
Prazeres has waived the white flag on a four-year suspension
for a second violation of UFC Anti-Doping Policy.
Prazere, 40, tested positive for multiple prohibited substances —
clomiphene and its metabolites (desethyl-clomiphene, clomiphene M1,
and clomiphene M2), oxandrolone metabolites, and the exogenous
administration of testosterone and/or its precursors via urine
samples — and will be banned from competition until Aug. 27, 2025.
Prazeres previously tested positive for boldenone in March of 2019
and served a two-year ban.
The United States Anti-Doping Agency on Thursday revealed the
suspension and issued the following statement:
Prazeres’ urine sample was analyzed using a specialized test,
known as Carbon Isotope Ratio (CIR) testing, that differentiates
between anabolic androgenic steroids (AAS) naturally produced by
the body and prohibited anabolic agents of external origin. The CIR
test confirmed the presence of testosterone and/or its precursors
of external origin in Prazeres’ urine sample. Anabolic agents have
powerful performance-enhancing capabilities and can give an athlete
an unfair advantage over fellow competitors.
Clomiphene is a Specified Substance in the category of Hormone and
Metabolic Modulators, while all AAS and oxandrolone are
non-Specified Substances in the class of Anabolic Agents.
Clomiphene, oxandrolone, and all AAS are prohibited at all times
under the UFC Anti-Doping Policy and UFC Prohibited List.